Research  >  About SRI  >  Scientist Profiles

Scientist profiles G-L

SRI Profiles

Dr. Andrea Gershon
Andrea Gershon, MD, M.Sc.


Sunnybrook Health Sciences Centre
2075 Bayview Ave., Room G1 06
Toronto, ON
M4N 3M5

Phone: 416-480-4758
Fax: 416-480-5153

Administrative Assistant: Violet Izevbigie
Phone: 416-480-4055, ext. 7737


  • MD, 1996, University of Toronto, Canada
  • M.Sc., 2003, U of T, Canada

Appointments and Affiliations:


  • Emerging Research Leaders Initiative Award, Heart and Stroke Foundation, Canadian Institutes of Health Research, Canadian Respiratory Research Network, 2016
  • Assembly on Behavioral Science and Health Services Research Early Career Achievement Award, American Thoracic Society, 2015
  • Early Researcher Award, Ontario Ministry of Research and Innovation and Ontario Ministry of Economic Development, 2015
  • New Investigator Award, Canadian Institutes of Health Research, 2014
  • Achievement, Commitment and Excellence Award, Ontario Ministry of Health and Long-Term Care, 2013
  • Graham Farquharson Fellowship for Translational Health Research, Physicians’ Services Incorporated Foundation, 2013

Research Foci:

  • Respiratory disease
  • Health services research
  • Population-based studies

Research Summary:

The focus of Dr. Gershon’s research is health outcomes, health services, quality of care and drug safety and effectiveness in people with respiratory disease.

Selected Publications:

See current publications list at PubMed.

  1. Gershon AS, Hwee J, Victor JC, Wilton D, Wu R, Day A, To T. Mortality trends in women and men with COPD in Ontario, Canada, 1996-2012. Thorax. 2015 Feb;70(2):121–6.
  2. Gershon AS, Campitelli MA, Croxford R, Stanbrook MB, To T, Upshur R, Stephenson A, Stukel TA. Combination long-acting beta-agonists and inhaled corticosteroids versus long-acting beta-agonists alone in older adults with chronic obstructive pulmonary disease. JAMA. 2014 Sep 17;312(11):1114–21.
  3. Gershon AS, Croxford R, Calzavara A, To T, Stanbrook M, Upshur R, Stukel T. Cardiovascular safety of inhaled long-acting bronchodilators in individuals with chronic obstructive pulmonary disease. JAMA Intern Med. 2013 Jul 8;173(13):1175–85.
  4. Gershon AS, Guan J, Victor JC, Goldstein R, To T. Quantifying health services use for chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013 Mar 15;187(6):596–601.
  5. Gershon AS, Warner L, Cascagnette P, Victor JC, To T. Lifetime risk of developing chronic obstructive pulmonary disease: a longitudinal population study. Lancet. 2011 Sep; 378(9795):991–96.

Related News and Stories:

Related Links: